{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:59:14Z","timestamp":1785531554172,"version":"3.56.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["HL128386"],"award-info":[{"award-number":["HL128386"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["HD084461"],"award-info":[{"award-number":["HD084461"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["HL132805"],"award-info":[{"award-number":["HL132805"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["TR000446"],"award-info":[{"award-number":["TR000446"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome","doi-asserted-by":"publisher","award":["1015006"],"award-info":[{"award-number":["1015006"]}],"id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000862","name":"Doris Duke foundations","doi-asserted-by":"publisher","award":["2017075"],"award-info":[{"award-number":["2017075"]}],"id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","sfnmjournal.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Fetal and Neonatal Medicine"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.siny.2018.02.006","type":"journal-article","created":{"date-parts":[[2018,2,24]],"date-time":"2018-02-24T17:59:49Z","timestamp":1519495189000},"page":"232-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Genetics of the patent ductus arteriosus (PDA) and pharmacogenetics of PDA treatment"],"prefix":"10.1016","volume":"23","author":[{"given":"Tamorah R.","family":"Lewis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine L.","family":"Shelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara L.","family":"Van Driest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prince J.","family":"Kannankeril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Reese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.siny.2018.02.006_bib1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1053\/j.semperi.2010.02.007","article-title":"Inadvertent relaxation of the ductus arteriosus by pharmacologic agents that are commonly used in the neonatal period","volume":"34","author":"Reese","year":"2010","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.siny.2018.02.006_bib2","doi-asserted-by":"crossref","first-page":"15054","DOI":"10.1073\/pnas.192582999","article-title":"Finding genetic contributions to sporadic disease: a recessive locus at 12q24 commonly contributes to patent ductus arteriosus","volume":"99","author":"Mani","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.siny.2018.02.006_bib3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1542\/peds.2007-2313","article-title":"Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institutes of health","volume":"122","author":"Lavoie","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2018.02.006_bib4","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1542\/peds.2008-1117","article-title":"Genetic contribution to patent ductus arteriosus in the premature newborn","volume":"123","author":"Bhandari","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2018.02.006_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000262481","article-title":"Insights into the pathogenesis and genetic background of patency of the ductus arteriosus","volume":"98","author":"Bokenkamp","year":"2010","journal-title":"Neonatology"},{"key":"10.1016\/j.siny.2018.02.006_bib6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1053\/j.semperi.2011.09.019","article-title":"Genetics of patent ductus arteriosus susceptibility and treatment","volume":"36","author":"Hajj","year":"2012","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.siny.2018.02.006_bib7","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1073\/pnas.98.3.1059","article-title":"Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2","volume":"98","author":"Loftin","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.siny.2018.02.006_bib8","doi-asserted-by":"crossref","first-page":"9759","DOI":"10.1073\/pnas.97.17.9759","article-title":"Coordinated regulation of fetal and maternal prostaglandins directs successful birth and postnatal adaptation in the mouse","volume":"97","author":"Reese","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.siny.2018.02.006_bib9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/36342","article-title":"The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth","volume":"390","author":"Nguyen","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.siny.2018.02.006_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1006\/bbrc.1998.8461","article-title":"Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice","volume":"246","author":"Segi","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.siny.2018.02.006_bib11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/CIRCULATIONAHA.109.862946","article-title":"Failure of postnatal ductus arteriosus closure in prostaglandin transporter-deficient mice","volume":"121","author":"Chang","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.siny.2018.02.006_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nm0202-91","article-title":"Metabolism of PGE2 by prostaglandin dehydrogenase is essential for remodeling the ductus arteriosus","volume":"8","author":"Coggins","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.siny.2018.02.006_bib13","article-title":"A\u00a0heart-hand syndrome gene: Tfap2b plays a critical role in the development and remodeling of mouse ductus arteriosus and limb patterning","volume":"6","author":"Zhao","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.siny.2018.02.006_bib14","first-page":"515","article-title":"Myocardin regulates expression of contractile genes in smooth muscle cells and is required for closure of the ductus arteriosus in mice","volume":"118","author":"Huang","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.siny.2018.02.006_bib15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/35014065","article-title":"Smooth-muscle contraction without smooth-muscle myosin","volume":"2","author":"Morano","year":"2000","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.siny.2018.02.006_bib16","doi-asserted-by":"crossref","first-page":"E3207","DOI":"10.1073\/pnas.1508386112","article-title":"BMP9 and BMP10 are necessary for proper closure of the ductus arteriosus","volume":"112","author":"Levet","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.siny.2018.02.006_bib17","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/dvg.22904","article-title":"Loss of Notch2 and Notch3 in vascular smooth muscle causes patent ductus arteriosus","volume":"53","author":"Baeten","year":"2015","journal-title":"Genesis"},{"key":"10.1016\/j.siny.2018.02.006_bib18","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1242\/dev.052043","article-title":"Patent ductus arteriosus in mice with smooth muscle-specific Jag1 deletion","volume":"137","author":"Feng","year":"2010","journal-title":"Development"},{"key":"10.1016\/j.siny.2018.02.006_bib19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nm.2060","article-title":"Platelets contribute to postnatal occlusion of the ductus arteriosus","volume":"16","author":"Echtler","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.siny.2018.02.006_bib20","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1128\/MCB.01338-10","article-title":"SWI\/SNF complexes containing Brahma or Brahma-related gene 1 play distinct roles in smooth muscle development","volume":"31","author":"Zhang","year":"2011","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.siny.2018.02.006_bib21","series-title":"GeneReviews\u00ae. Seattle","article-title":"Cantu syndrome and related disorders","author":"Grange","year":"1993"},{"key":"10.1016\/j.siny.2018.02.006_bib22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/75578","article-title":"Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus","volume":"25","author":"Satoda","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.siny.2018.02.006_bib23","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ng1721","article-title":"Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm\/aortic dissection and patent ductus arteriosus","volume":"38","author":"Zhu","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.siny.2018.02.006_bib24","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/ng.2007.6","article-title":"Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections","volume":"39","author":"Guo","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.siny.2018.02.006_bib25","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1542\/peds.2008-0313","article-title":"Determination of genetic predisposition to patent ductus arteriosus in preterm infants","volume":"123","author":"Dagle","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2018.02.006_bib26","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1203\/01.PDR.0000088016.67117.39","article-title":"Angiotensin II type 1 receptor A1166C polymorphism and prophylactic indomethacin treatment induced ductus arteriosus closure in very low birth weight neonates","volume":"54","author":"Treszl","year":"2003","journal-title":"Pediatr Res"},{"key":"10.1016\/j.siny.2018.02.006_bib27","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1515\/JPM.2005.082","article-title":"Gender dependent association between perinatal morbidity and estrogen receptor-alpha Pvull polymorphism","volume":"33","author":"Derzbach","year":"2005","journal-title":"J\u00a0Perinat Med"},{"key":"10.1016\/j.siny.2018.02.006_bib28","doi-asserted-by":"crossref","first-page":"F25","DOI":"10.1136\/adc.2005.086421","article-title":"Association of interferon gamma T+874A and interleukin 12 p40 promoter CTCTAA\/GC polymorphism with the need for respiratory support and perinatal complications in low birthweight neonates","volume":"92","author":"Bokodi","year":"2007","journal-title":"Archs Dis Childh"},{"key":"10.1016\/j.siny.2018.02.006_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41372-018-0052-8","article-title":"Precision therapeutics in the NICU: why are we missing the mark?","author":"Lewis","year":"2018","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.siny.2018.02.006_bib30","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jpeds.2015.07.011","article-title":"Effects of advancing gestation and non-caucasian race on ductus arteriosus gene expression","volume":"167","author":"Waleh","year":"2015","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.siny.2018.02.006_bib31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0090-6980(75)90034-9","article-title":"Lamb ductus arteriosus: effect of prostaglandin synthesis inhibitors on the muscle tone and the response to prostaglandin E2","volume":"9","author":"Coceani","year":"1975","journal-title":"Prostaglandins"},{"key":"10.1016\/j.siny.2018.02.006_bib32","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJM197609022951003","article-title":"Pharmacologic closure of patent ductus arteriosus in the premature infant","volume":"295","author":"Friedman","year":"1976","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.siny.2018.02.006_bib33","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1056\/NEJM197609022951004","article-title":"Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis","volume":"295","author":"Heymann","year":"1976","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.siny.2018.02.006_bib34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF00561483","article-title":"Effectiveness and pharmacokinetics of indomethacin in premature newborns with patent ductus arteriosus","volume":"18","author":"Vert","year":"1980","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.siny.2018.02.006_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000457493","article-title":"Metabolism and disposition of indomethacin in preterm infants","volume":"17","author":"Friedman","year":"1991","journal-title":"Dev Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.siny.2018.02.006_bib36","article-title":"Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants","author":"Ohlsson","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.siny.2018.02.006_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003480.pub3","article-title":"Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants","author":"Herrera","year":"2007","journal-title":"Cochrane Database Syst Rev (online)"},{"key":"10.1016\/j.siny.2018.02.006_bib38","doi-asserted-by":"crossref","first-page":"F116","DOI":"10.1136\/adc.2011.215160","article-title":"Pharmacokinetics of oral ibuprofen for patent ductus arteriosus closure in preterm infants","volume":"97","author":"Barzilay","year":"2012","journal-title":"Arch Dis Childh Fetal Neonatal Ed"},{"key":"10.1016\/j.siny.2018.02.006_bib39","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2125.2008.03118.x","article-title":"An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study","volume":"65","author":"Hirt","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.siny.2018.02.006_bib40","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/FTD.0b013e31815b3e13","article-title":"Orogastric and intravenous indomethacin administration to very premature neonates with patent ductus arteriosus: population pharmacokinetics, absolute bioavailability, and treatment outcome","volume":"29","author":"Al Za\u2019abi","year":"2007","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.siny.2018.02.006_bib41","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2125.2004.02139.x","article-title":"Intravenous indometacin in preterm infants with symptomatic patent ductus arteriosus. A population pharmacokinetic study","volume":"58","author":"Smyth","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.siny.2018.02.006_bib42","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s10549-014-3105-5","article-title":"Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel","volume":"147","author":"Vulsteke","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.siny.2018.02.006_bib43","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4103\/0253-7613.140594","article-title":"CYP2C9*3 polymorphism presenting as lethal subdural hematoma with low-dose warfarin","volume":"46","author":"Karnik","year":"2014","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.siny.2018.02.006_bib44","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/pr.2017.145","article-title":"Polymorphisms in CYP2C9 are associated with response to indomethacin among neonates with patent ductus arteriosus","volume":"82","author":"Smith","year":"2017","journal-title":"Pediatr Res"},{"key":"10.1016\/j.siny.2018.02.006_bib45","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/FPC.0b013e32830b0c5e","article-title":"Structure and characterization of human carboxylesterase 1A1, 1A2, and 1A3 genes","volume":"18","author":"Fukami","year":"2008","journal-title":"Pharmacogenet Genom"},{"key":"10.1016\/j.siny.2018.02.006_bib46","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2217\/pgs.15.7","article-title":"Individualization of treatments with drugs metabolized by CES1: combining genetics and metabolomics","volume":"16","author":"Rasmussen","year":"2015","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.siny.2018.02.006_bib47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.siny.2004.11.001","article-title":"Ontogeny of drug metabolizing enzymes in the neonate","volume":"10","author":"Blake","year":"2005","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.siny.2018.02.006_bib48","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1124\/dmd.115.068957","article-title":"Age-dependent human hepatic carboxylesterase 1 (CES1) and carboxylesterase 2 (CES2) postnatal ontogeny","volume":"44","author":"Hines","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.siny.2018.02.006_bib49","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2125.2004.02183.x","article-title":"The effect of the cytochrome P450 CYP2C8 polymorphism on the disposition of (R)-ibuprofen enantiomer in healthy subjects","volume":"59","author":"Martinez","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.siny.2018.02.006_bib50","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clpt.2004.04.006","article-title":"Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms","volume":"76","author":"Garcia-Martin","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.siny.2018.02.006_bib51","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1067\/mcp.2002.125726","article-title":"Enantiospecific effects of cytochrome P450 2C9 amino acid variants on ibuprofen pharmacokinetics and on the inhibition of cyclooxygenases 1 and 2","volume":"72","author":"Kirchheiner","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.siny.2018.02.006_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012329","article-title":"Are cytochrome P450 CYP2C8 and CYP2C9 polymorphisms associated with ibuprofen response in very preterm infants?","volume":"5","author":"Durrmeyer","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.siny.2018.02.006_bib53","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000345337","article-title":"Intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants","volume":"103","author":"Oncel","year":"2013","journal-title":"Neonatology"},{"key":"10.1016\/j.siny.2018.02.006_bib54","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00431-016-2731-9","article-title":"Intravenous paracetamol for PDA closure in the preterm: a single-center experience","volume":"175","author":"Valerio","year":"2016","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.siny.2018.02.006_bib55","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3109\/14767058.2012.755162","article-title":"A\u00a0different first-choice drug in the medical management of patent ductus arteriosus: oral paracetamol","volume":"26","author":"Yurttutan","year":"2013","journal-title":"J\u00a0Maternal\u2013Fetal Neonatal Med"},{"key":"10.1016\/j.siny.2018.02.006_bib56","doi-asserted-by":"crossref","DOI":"10.5812\/ijp.3975","article-title":"Comparison of oral acetaminophen versus ibuprofen in premature infants with patent ductus arteriosus","volume":"26","author":"Bagheri","year":"2016","journal-title":"Iran J Pediatr"},{"key":"10.1016\/j.siny.2018.02.006_bib57","first-page":"246","article-title":"Safety and population pharmacokinetic analysis of intravenous acetaminophen in neonates, infants, children, and adolescents with pain or fever","volume":"16","author":"Zuppa","year":"2011","journal-title":"J\u00a0Pediatr Pharmacol Ther"},{"key":"10.1016\/j.siny.2018.02.006_bib58","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/cpt1976193284","article-title":"Acetaminophen elimination kinetics in neonates, children, and adults","volume":"19","author":"Miller","year":"1976","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.siny.2018.02.006_bib59","first-page":"497","article-title":"Sulphation of acetaminophen by the human cytosolic sulfotransferases: a systematic analysis","volume":"158","author":"Yamamoto","year":"2015","journal-title":"J\u00a0Biochem"},{"key":"10.1016\/j.siny.2018.02.006_bib60","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/gut.50.2.259","article-title":"Developmental aspects of human hepatic drug glucuronidation in young children and adults","volume":"50","author":"Strassburg","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.siny.2018.02.006_bib61","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1124\/jpet.105.093633","article-title":"Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre- and postnatal human liver","volume":"316","author":"Duanmu","year":"2006","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.siny.2018.02.006_bib62","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1007\/s11095-013-1007-6","article-title":"Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis","volume":"30","author":"McGill","year":"2013","journal-title":"Pharm Res"},{"key":"10.1016\/j.siny.2018.02.006_bib63","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1124\/jpet.112.202010","volume":"345","author":"Court","year":"2013","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.siny.2018.02.006_bib64","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1124\/mol.105.019240","article-title":"Sulfotransferase (SULT) 1A1 polymorphic variants *1, *2, and *3 are associated with altered enzymatic activity, cellular phenotype, and protein degradation","volume":"69","author":"Nagar","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.siny.2018.02.006_bib65","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/hmg\/ddl468","article-title":"Human SULT1A1 gene: copy number differences and functional implications","volume":"16","author":"Hebbring","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.siny.2018.02.006_bib66","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000243418","article-title":"Symptomatic patent ductus arteriosus following prophylactic indomethacin. A clinical and biochemical appraisal","volume":"60","author":"Cotton","year":"1991","journal-title":"Biol Neonate"},{"key":"10.1016\/j.siny.2018.02.006_bib67","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jpeds.2007.05.007","article-title":"Risk factors for persistent ductus arteriosus patency during indomethacin treatment","volume":"151","author":"Chorne","year":"2007","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.siny.2018.02.006_bib68","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jpeds.2015.07.011","article-title":"Effects of advancing gestation and non-caucasian race on ductus arteriosus gene expression","volume":"167","author":"Waleh","year":"2015","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.siny.2018.02.006_bib69","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.clpt.2006.01.013","article-title":"Genetically mediated interindividual variation in analgesic responses to cyclooxygenase inhibitory drugs","volume":"79","author":"Lee","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.siny.2018.02.006_bib70","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1203\/PDR.0b013e3181ed8609","article-title":"Patterns of gene expression in the ductus arteriosus are related to environmental and genetic risk factors for persistent ductus patency","volume":"68","author":"Waleh","year":"2010","journal-title":"Pediatr Res"},{"key":"10.1016\/j.siny.2018.02.006_bib71","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/hrt.30.1.4","article-title":"Natural history of persistent ductus arteriosus","volume":"30","author":"Campbell","year":"1968","journal-title":"Br Heart J"},{"key":"10.1016\/j.siny.2018.02.006_bib72","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1542\/peds.2008-2418","article-title":"Failure of ductus arteriosus closure is associated with increased mortality in preterm infants","volume":"123","author":"Noori","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2018.02.006_bib73","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1651-2227.2002.tb01668.x","article-title":"Changes in cerebral, renal and mesenteric blood flow velocity during continuous and bolus infusion of indomethacin","volume":"91","author":"Christmann","year":"2002","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.siny.2018.02.006_bib74","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.clp.2011.12.002","article-title":"Evidence-based use of indomethacin and ibuprofen in the neonatal intensive care unit","volume":"39","author":"Johnston","year":"2012","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.siny.2018.02.006_bib75","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/j.semperi.2011.09.024","article-title":"Pros and cons of patent ductus arteriosus ligation: hemodynamic changes and other morbidities after patent ductus arteriosus ligation","volume":"36","author":"Noori","year":"2012","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.siny.2018.02.006_bib76","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.semperi.2011.09.020","article-title":"The ductus arteriosus: a refined approach!","volume":"36","author":"Sehgal","year":"2012","journal-title":"Semin perinatol"},{"key":"10.1016\/j.siny.2018.02.006_bib77","first-page":"139","article-title":"Percutaneous patent ductus arteriosus (PDA) closure during infancy: a meta-analysis","author":"Backes","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2018.02.006_bib78","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.acvd.2014.01.008","article-title":"Transcatheter closure of patent ductus arteriosus: past, present and future","volume":"107","author":"Baruteau","year":"2014","journal-title":"Archs Cardiovasc Dis"},{"key":"10.1016\/j.siny.2018.02.006_bib79","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1053\/euhj.1998.0977","article-title":"Stent implantation of the arterial duct in newborns with duct-dependent circulation","volume":"19","author":"Schneider","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.siny.2018.02.006_bib80","doi-asserted-by":"crossref","first-page":"58","DOI":"10.20452\/pamw.2081","article-title":"Therapeutic manipulation of the ductus arteriosus: current options and future prospects","volume":"124","author":"Coceani","year":"2014","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/j.siny.2018.02.006_bib81","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/01.CIR.64.5.893","article-title":"Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease","volume":"64","author":"Lewis","year":"1981","journal-title":"Circulation"},{"key":"10.1016\/j.siny.2018.02.006_bib82","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd892","article-title":"The druggable genome","volume":"1","author":"Hopkins","year":"2002","journal-title":"Nature Rev Drug Discov"},{"key":"10.1016\/j.siny.2018.02.006_bib83","first-page":"9","article-title":"The druggable genome and support for target identification and validation in drug development","author":"Finan","year":"2017","journal-title":"Science Transl Med"},{"key":"10.1016\/j.siny.2018.02.006_bib84","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/2045-3701-3-8","article-title":"Non-steroid anti-inflammatory drugs, prostaglandins, and cancer","volume":"3","author":"Allaj","year":"2013","journal-title":"Cell Biosci"},{"key":"10.1016\/j.siny.2018.02.006_bib85","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/jp.2011.153","article-title":"Reversal of fetal ductal constriction after maternal restriction of polyphenol-rich foods: an open clinical trial","volume":"32","author":"Zielinsky","year":"2012","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.siny.2018.02.006_bib86","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1152\/physiolgenomics.00171.2013","article-title":"Transcriptional profiling reveals ductus arteriosus-specific genes that regulate vascular tone","volume":"46","author":"Shelton","year":"2014","journal-title":"Physiol Genom"},{"key":"10.1016\/j.siny.2018.02.006_bib87","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1152\/physiolgenomics.00007.2006","article-title":"Maternal vitamin A alters gene profiles and structural maturation of the rat ductus arteriosus","volume":"31","author":"Yokoyama","year":"2007","journal-title":"Physiol Genom"},{"key":"10.1016\/j.siny.2018.02.006_bib88","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12576-011-0133-3","article-title":"DNA microarray profiling identified a new role of growth hormone in vascular remodeling of rat ductus arteriosus","volume":"61","author":"Jin","year":"2011","journal-title":"J\u00a0Physiol Sci"},{"key":"10.1016\/j.siny.2018.02.006_bib89","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1651-2227.2012.02699.x","article-title":"Unexpected extra-renal effects of loop diuretics in the preterm neonate","volume":"101","author":"Cotton","year":"2012","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.siny.2018.02.006_bib90","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1161\/01.CIR.0000141292.28616.65","article-title":"Oxygen-sensitive Kv channel gene transfer confers oxygen responsiveness to preterm rabbit and remodeled human ductus arteriosus: implications for infants with patent ductus arteriosus","volume":"110","author":"Thebaud","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.siny.2018.02.006_bib91","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/CIRCULATIONAHA.106.649566","article-title":"Oxygen activates the Rho\/Rho-kinase pathway and induces RhoB and ROCK-1 expression in human and rabbit ductus arteriosus by increasing mitochondria-derived reactive oxygen species: a newly recognized mechanism for sustaining ductal constriction","volume":"115","author":"Kajimoto","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.siny.2018.02.006_bib92","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/FJC.0b013e318070d1bd","article-title":"Rho kinase (ROCK) inhibitors","volume":"50","author":"Liao","year":"2007","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.siny.2018.02.006_bib93","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/978-1-4614-0899-4_23","article-title":"Notch inhibition as a promising new approach to cancer therapy","volume":"727","author":"Purow","year":"2012","journal-title":"Adv Exp Med Biol"}],"container-title":["Seminars in Fetal and Neonatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X18300398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X18300398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:37:38Z","timestamp":1751416658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1744165X18300398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":93,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1744165X18300398"],"URL":"https:\/\/doi.org\/10.1016\/j.siny.2018.02.006","relation":{},"ISSN":["1744-165X"],"issn-type":[{"value":"1744-165X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetics of the patent ductus arteriosus (PDA) and pharmacogenetics of PDA treatment","name":"articletitle","label":"Article Title"},{"value":"Seminars in Fetal and Neonatal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.siny.2018.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}